Virtual Library
Start Your Search
F. Suárez
Author of
-
+
P1.08 - Poster Session with Presenters Present (ID 460)
- Event: WCLC 2016
- Type: Poster Presenters Present
- Track: Surgery
- Presentations: 1
- Moderators:
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.08-025 - Long-Term Survival of Lung Cancer in Chile (ID 6223)
14:30 - 14:30 | Author(s): F. Suárez
- Abstract
Background:
Lung cancer is the leading cause of cancer death worldwide. The long-term survival is an important outcome of oncologic therapies. In early stages permits to evaluate the quality of surgical oncology services, meanwhile in advanced stages the quality of the multidisciplinary teams. Screening programs and early diagnosis are the most efficient way to achieve increase in overall survival. The results of Clínica Santa Maria in Lung Cancer patients are presented.
Methods:
All patients diagnosed with Non-small Lung Cancer, treated by the team of Thoracic Surgery in our private hospital, during the period January 2011 to July 2016 were entered prospectively, consecutively and daily to a web database. Demographic, clinical and pathological data, as well as monitoring all events were recorded. All our patients underwent to an exhaustive staging process. Statistical descriptive analysis of clinical and demographic variables and 5 year overall survival are shown.
Results:
313 patients were included, median age of 65 years old (32-89), 48,6% female. Adenocarcinoma was the most frequent histology (78,9%). Stage I 48,6%, Stage II 9,27%, Stage III 14,8%, and Stage IV 26,5%. The median follow-up time was 50 months (1-289) with a mean survival time of 99 months. Overall 5-year survival was 63,7% (95%CI, 57-69%), and by stages: Stage I 91,4% (95%CI, 84,9-95,2%), Stage II 63,7% (95%CI, 39,5-80,3%), Stage III 44,3% (95%CI, 26,4-60,8%) and Stage IV 19,1% (95%CI, 10,1-30,3%). Adenocarcinomas was 64% (95%CI, 56,6-70,5%). Figure 1
Conclusion:
The epidemiological profile of our patients is similar to those published in most of the World Series. The diagnosis in early stages is high, further up than most publications, however, lower than those shown by Asamura, who reported 58,6%. We believe that the overall survival of this series results are superior to most international publications, due to the high percentage of patients in early stages, exhaustive staging and adequate multidisciplinary treatment.
